BOC Sciences, a leading global supplier and manufacturer of premium chemicals, has recently announced the launch of impurities synthesis for API development, expanding its custom synthesis service portfolio.
Shirley, NY, USA–BOC Sciences, a US-based global supplier of cost-effective chemicals, biochemicals and efficient custom drug development services, has newly announced Impurities Synthesis for API development, expanding its custom synthesis service portfolio. The service covers general and custom needs of global clients and provides academic and pharmaceutical labs with cost-effective prices. It’s a new step for BOC Sciences as well as a good news for academic institutes, research labs and pharmaceutical companies since they now have a good alternative of API impurities for drug discovery and production.
Impurities play important roles in active pharmaceutical ingredient (API) development. Their scales and side pharmaceutical effects are closely related to the efficiency and safety of APIs, which may cause the failure of developing a potential drug or meeting the quality standard in drug production. Since the International Conference on Harmonization (ICH) has published a series of guidelines for impurities level control, suggesting at least 0.1% or more in drug manufacturing, the pharmaceutical industry has seen an increasing demand for drug impurities and impurities synthesis.
“The outcome of this service was based on large demands from the company’s global clients with their increasing needs for custom synthesis.” Says Jimmy, the Business Development Executive of BOC Sciences, “In fact, we had held rich enough experience in the synthesis of chemicals for nearly a decade. It’s just a matter of time for us to bring out this service as a complement of API synthesis.”
BOC Sciences is always ambitious in manufacturing premium chemicals. The company never stops its steps to expand its product and service portfolio. Up to now, the company provides thousands of chemical products including APIs for Veterinary, chemical building blocks, GMP Products, metabolites, chiral reagent, and etc. It also provides a wide span of pharmaceutical services including custom synthesis of those chemicals both in stock and not in stock, chiral synthesis and chiral resolution, bio-conjugation, analytical services, and etc.
“We take different strategies to impurities synthesis according to various sources of impurities.” Adds Dr. Green, Scientist Representative in the Drug Discovery Division of the company, “With a team of expert scientists, we excel at designing the routine and using multiple techniques to analyze compounds after the impurities synthesis is completed. X-ray and NMR, for instance.”
Impurities provided by BOC Sciences now could be synthesized in milligram to gram scale, mainly depending on specific demands. Visit the company’s official website for more detailed information (www.bocsci.com/solutions/impurities-synthesis.htm) or contact email@example.com for custom inquiry. The company provides customer service at business hours per day, Monday through Friday.
About BOC Sciences:
BOC Sciences is a brand of BOCSCI Inc., which is based in Shirley, NY, USA. The company is credited by its clients in 26 different countries by providing comprehensive pharmaceutical services for nearly a decade. It holds great confidence in its chemical products and chemical synthesis with its advanced platforms and a expert scientist team. Dedicated to be a trusted business, BOC Sciences is customer-centered and strives to accelerate the speed of chemical science and drug development.